Exane Derivatives’s TechnipFMC FTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-81
Closed -$70 845
2020
Q3
$70 Sell
81
-53
-40% -$298 ﹤0.01% 734
2020
Q2
$111 Sell
134
-81
-38% -$472 ﹤0.01% 666
2020
Q1
$176 Sell
215
-20
-9% -$220 ﹤0.01% 661
2019
Q4
$17.5K Buy
235
+97
+70% +$1.5K ﹤0.01% 400
2019
Q3
$13.9K Buy
138
+51
+59% +$951 ﹤0.01% 411
2019
Q2
$15.1K Sell
87
-875
-91% -$15.3K ﹤0.01% 436
2019
Q1
$52K Buy
962
+106
+12% +$1.79K 0.01% 337
2018
Q4
$1.69M Sell
856
-3,812
-82% -$70.9K 0.3% 84
2018
Q3
$223K Sell
4,668
-3,033
-39% -$68.8K 0.04% 234
2018
Q2
$657K Buy
7,701
+6,626
+616% +$158K 0.11% 155
2018
Q1
$90.4K Buy
1,075
+597
+125% +$13.8K 0.02% 312
2017
Q4
$833K Sell
478
-5,987
-93% -$124K 0.14% 114
2017
Q3
$1.5M Sell
6,465
-5,365
-45% -$108K 0.28% 68
2017
Q2
$1.27M Buy
11,830
+1,540
+15% +$34.7K 0.27% 86
2017
Q1
$396K Buy
+10,290
New +$254K 0.09% 145

Other funds holding FTI

Exane Derivatives's FTI Position: Q2 2022 in Review

Exane Derivatives opened a new position in TechnipFMC (FTI) in Q2 2022: 65,500 shares worth $441K. The stake represents 0.25% of the portfolio and ranks #100 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in FTI as recently as Q4 2021.

Exane Derivatives first reported a position in FTI in Q1 2017 and has held it in 20 quarters since. The position peaked at $13.7M in Q3 2017. 252 funds tracked by Wall St. Rank hold FTI as of Q2 2022.

  • Exane Derivatives held 65,500 shares of TechnipFMC worth $441K as of Q2 2022.
  • TechnipFMC was a new Exane Derivatives position in Q2 2022.
  • TechnipFMC made up 0.25% of Exane Derivatives's portfolio in Q2 2022, its #100 holding.
  • Exane Derivatives first reported a position in TechnipFMC in Q1 2017 and has held it in 20 quarters since.
  • Exane Derivatives's TechnipFMC position peaked at $13.7M in Q3 2017.
  • 252 funds tracked by Wall St. Rank held TechnipFMC as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.